Doctor profile · Federal record

Dr. Isabelle Zamfirescu, MD

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · South Weymouth, MA

  • NPI 1881802031
  • Accepts Medicare
  • 21 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
541 Main St, Suite 210
South Weymouth, MA 021901868
(781) 952-1280
fax (781) 952-1570

Credentials & registration

NPPES · NUCC
NPI registered
May 2007 — 19 yrs on file
Profile last updated
April 20, 2010
Year of graduation
2005 — 21 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
Massachusetts #242591

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1881802031. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
9,427
Distinct HCPCS
10
Medicare allowed
$290,159
HCPCS Description Services Patients Avg allowed
J0897 Injection, denosumab, 1 mg 7,800 87 $23
36415 Insertion of needle into vein for collection of blood sample 458 344 $8
99214 Established patient office or other outpatient visit, 30-39 minutes 408 284 $139
J3489 Injection, zoledronic acid, 1 mg 222 46 $9
99213 Established patient office or other outpatient visit, 20-29 minutes 171 164 $99
96372 Injection of drug or substance under skin or into muscle 149 93 $16
99204 New patient office or other outpatient visit, 45-59 minutes 49 49 $180
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 43 43 $75
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes 23 23 $88
99215 Established patient office or other outpatient visit, 40-54 minutes 21 20 $196

In context: peer comparison

Among 3 peers in this city , average services per provider: 579. This provider delivers 16× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$110
Transactions
1
Manufacturers
1
Payer (manufacturer) Industry Txns Amount
Abbott Laboratories 1 $109.98

By nature of payment

Long term medical supply or device loan
$110

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,187
Patients
742
Total drug cost
$796,558
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 382 129 $6,613
Trulicity (Dulaglutide) Brand 217 48 $262,587
Metformin Hcl Er (Metformin Hcl) Brand 211 87 $4,000
Glipizide Er (Glipizide) Brand 194 66 $6,236
Nano 2nd Gen Pen Needle (Pen Needle, Diabetic) Brand 160 66 $17,476
Ozempic (Semaglutide) Brand 153 32 $200,527
Metformin Hcl Generic 125 49 $4,473
Basaglar Kwikpen U-100 (Insulin Glargine,hum.Rec.Anlog) Brand 122 39 $88,677
Atorvastatin Calcium Generic 118 53 $2,433
Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) Brand 115 46 $81,525

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Isabelle Zamfirescu's medical specialty?
Dr. Isabelle Zamfirescu practices Endocrinology, Diabetes & Metabolism Physician in South Weymouth, MA.
Where does Dr. Isabelle Zamfirescu practice?
Dr. Isabelle Zamfirescu practices at 541 Main St, South Weymouth, MA 021901868. Office phone: 7819521280.
What is Dr. Isabelle Zamfirescu's NPI?
Dr. Isabelle Zamfirescu's National Provider Identifier (NPI) is 1881802031, issued by NPPES.
Does Dr. Isabelle Zamfirescu accept Medicare assignment?
Yes. Dr. Isabelle Zamfirescu accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Isabelle Zamfirescu commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Insertion of needle into vein for collection of blood sample (HCPCS 36415); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.